ClinConnect ClinConnect Logo
Search / Trial NCT00033969

Study of Proteins Associated With Complex Regional Pain Syndrome

Launched by NATIONAL INSTITUTE OF NURSING RESEARCH (NINR) · Apr 17, 2002

Trial Information

Current as of June 23, 2025

Terminated

Keywords

Crps Rsd Causalgia Chronic Pain Neuropathic Pain Normal Control Complex Regional Pain Syndrome Healthy Volunteer Hv

ClinConnect Summary

The etiology of Complex Regional Pain Syndrome (CRPS) is unknown but a patient typically presents with a triad of clinical findings: sensory abnormalities, perfusion abnormalities and alterations in motor function. Since some of these findings are seen in the other disease states, the diagnosis is often not clear. A response to a sympathetic ganglion block (stellate or lumbar) is also suggestive of the disorder. However, there is no definitive diagnostic test for CRPS. Experience has shown that early aggressive treatment improves the prognosis. Therefore, tests that facilitate the early dia...

Gender

ALL

Eligibility criteria

  • INCLUSION CRITERIA
  • Male or female patients referred by their physician with the diagnosis of CRPS criteria as outlined by Stanton-Hicks et al.
  • OR
  • Healthy volunteers will be screened according to the eligibility criteria as specified in the appendix (see Healthy Subject Eligibility).
  • Age restrictions: Patients and volunteers must be (Bullet)18 years of age at the time of enrollment. There is no upper limit for age of inclusion.
  • Good general health (other disease states could may confound the results see exclusion criteria)
  • Willing to have blood drawn
  • Willing to have behavioral measures
  • Willing to provide a directed medical history
  • There is expected to be a greater number of females than males being recruited to this study since there is a much higher occurrence of CRPS in women. Additionally, it is expected to be equal across all ethnic groups. However, we do not anticipate requiring any special recruiting strategies for specific gender or ethnic groups.
  • EXCLUSION CRITERIA
  • Contraindication to blood screening
  • Advanced disease other than the CRPS (cardiovascular, liver, kidney disease ASA III or above excluding CRPS) that may cause a theoretical inclusion of samples resulting in confounding results.
  • Pregnant and lactating women.
  • No exclusions will be made based on race, gender, or religion.

About National Institute Of Nursing Research (Ninr)

The National Institute of Nursing Research (NINR) is a prominent component of the National Institutes of Health (NIH), dedicated to advancing the science of nursing through rigorous research and evidence-based practice. NINR aims to enhance the health and well-being of individuals, families, and communities by funding and conducting innovative studies that address critical health issues. With a strong emphasis on promoting health equity and improving patient outcomes, NINR collaborates with a diverse range of stakeholders, including researchers, healthcare professionals, and policymakers, to translate research findings into effective interventions and health policies. Through its commitment to nursing research, NINR plays a vital role in shaping the future of healthcare and improving the quality of life for populations across the nation.

Locations

Bethesda, Maryland, United States

Patients applied

0 patients applied

Trial Officials

Andrew J Mannes, M.D.

Principal Investigator

National Institutes of Health Clinical Center (CC)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials